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INTRODUCTION
The phenomenon of age-related mus-
cle wasting has been long recognized
by geriatricians, rehabilitation specialists,
and public health practitioners. However,
Federal agencies are slow to recognize sar-
copenia as a diagnostic term despite the
ubiquitous observation of muscle loss as
a signature event of aging. The formal
adoption of sarcopenia as a clinical diag-
nosis has been complicated by its evolv-
ing operational definition and the varied
approaches to the assessment of lean body
mass (LBM). Currently, formal assess-
ments of LBM rarely occur within the con-
text of standard geriatric care. The failure
to adequately assess muscle tissue within
the larger context of geriatric medical care
has significant public health implications
given the importance of adequate mus-
cle function for “successful aging” and the
maintenance of independent living (Visser
and Schaap, 2011).
The prevalence of sarcopenia is approx-
imately 25% of the U.S. population over
70 years of age (Baumgartner et al., 1998;
Lorenzo, 2009). Additionally, U.S. health
care expenditures ascribed to sarcope-
nia, based on the Third National Health
and Nutritional Examination Survey
(NHANES III) data, have been conser-
vatively estimated at 11.8 billion dollars
(Janssen et al., 2004a). Given the national
trends in the Veteran population with
respect to age, reported disability levels,
and increased representation of African
American soldiers, the potential impact
of sarcopenia on the Veterans Health
Administration (VHA) healthcare system
merits consideration.
AFRICAN AMERICANS AND THE VHA
HEALTHCARE SYSTEM
The total Veteran population was esti-
mated to be over 22 million in 2012
which also includes approximately 2.2
million women. There was significant
minority representation among Veterans
during this same period with African
Americans members totaling 2.6 mil-
lion men and 430,000 women. The 2011
Veteran Population Projection Model (VA
Office of the Actuary, 2011) projects
a nearly 35% decrease in the total
Veteran population between 2013 and
2040. Nonetheless, this population trend
will be countered by an anticipated con-
comitant increase in the percentage of
minority Veterans from 21 to 34% during
this same time period. African Americans
will constitute the largest proportion of
this projected demographic shift in the
Veteran population (National Center for
Veterans Analysis and Statistics, 2011).
These changes reflect the advent of the
All-Voluntary Force and recent military
conflicts such as the Gulf War I and II
which were notable for the high pro-
portion of participating minority service
members with nearly one in three soldiers
being African American (Census Bureau,
2010). It is important to note that the
Veteran population is older than the gen-
eral population with a median age of
62 in comparison with a non-Veteran
median age of 43. The oldest Veterans
reflect a larger proportion of Caucasians
(Census Bureau, 2010; National Center for
Veterans Analysis and Statistics, 2011) as
their median age is 64 in comparison to
minority Veterans who have a median age
of 54–57. However, the relatively younger
subset of minority Veterans coupled with
the projected demographic changes sug-
gest that the need to effectively manage
geriatric syndromes in African Americans
within the VHA healthcare system will
continue to increase over time.
SARCOPENIA: DIAGNOSTIC
CONSIDERATIONS FOR AFRICAN
AMERICANS
Sarcopenia is an age-related syndrome
characterized by a decrease in muscle mass
and associated with a loss of strength
and power, diminished functional perfor-
mance, and increased disability (Newman
et al., 2003;Morley et al., 2011). The obser-
vation that basic mobility and indepen-
dent living status may be more dependent
on lower extremity muscle performance
rather than LBM in older adults (Visser
et al., 2000; Kamel, 2003) was the impetus
for some investigators to ascribe specific
terms (e.g., dynapenia and kratopenia), to
characterize the age-related loss of mus-
cle force and power (Morley et al., 2011).
Moreover, the Foundation for the National
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Institutes of Health Sarcopenia Project has
proposed to qualify sarcopenia as a form of
skeletal muscle function deficit to reflect the
varied etiology of mobility impairments
(Correa-de-Araujo and Hadley, 2014).
The recognition of total bodymass or body
fat as independent factors that influence
functional status gave rise to sarcopenic
index measures that combine these vari-
ables with estimates of LBM (Newman
et al., 2003). Consensus groups such as the
European Working Group on Sarcopenia
in Older People (EWGSOP) (Cruz-Jentoft
et al., 2010) have proposed a staged diag-
nostic criteria for sarcopenia that include
elements of LBM, strength, and functional
performance in response to these contem-
porary research findings (Table 1). These
consensus groups have recommended cus-
tomary walking speed as a key compo-
nent of the sarcopenia screening criteria,
and the Society for Sarcopenia, Cachexia
and Wasting Disorders (SSCWD) has
recommended that only older adults with
mobility deficits and/or a history of
falls should be considered for sarcope-
nia screening (Morley et al., 2011). This
screening model has potential shortcom-
ings that may be cause for concern. Just as
bone fracture is the signal event of osteo-
porosis, an observed functional limitation
may be deemed a signal event of sarcope-
nia. Moreover, it remains an open question
if these aforementioned conditions for sar-
copenia screening, derived largely from
population-based studies involving rela-
tively healthy community-dwelling adults
(Dam et al., 2014), are appropriate for
usage among a Veteran population with a
high prevalence of comorbid conditions.
RACIAL/ETHNIC CONSIDERATIONS
FOR BODY COMPOSITION
ASSESSMENT
Despite the recent evolution of the
diagnostic criteria for sarcopenia, the
assessment of LBM remains vital to our
understanding and clinical management
of age-related muscle dysfunction. A crit-
ical issue to consider in addressing
possible sarcopenia disparities in African
Americans is the influence of racial/ethnic
characteristics on common methods of
body composition assessment. African
Americans have approximately 5–8%
higher levels of muscle mass in compar-
ison to Caucasians based on total body
potassium assessment (TBK), and this dif-
ference applies to both men and women
and persists from childhood to old age
(Ortiz et al., 1992). African Americans
may also have 7–10% greater levels of
bone mineral density (BMD) as measured
with dual-energy X-ray absorptiometry
(DXA), even when controlling for LBM
and stature in men (Ettinger et al., 1997).
However, the rate of age-related LBM and
BMD loss may be similar between the two
races (Cohn et al., 1977). In addition, the
distribution of body fat differs between
these groups as Caucasians have greater
skinfold thickness in their chest, abdomen,
Table 1 | Categories of the sarcopenia syndrome based on causative factors, body composition, and stages of severity.
Causative factors Body composition Staging
Primary Sarcopenia Age-related only Sarcopenia LBM loss criterion onlyb Pre-
sarcopenia
LBM loss criterion
onlyb
Secondary Sarcopenia
Contributing comorbid
factors and behavioral
conditions
• Activity-related
• Disease-related
• Nutrition-related
Sarcopenia class:
aLM/h2
• Class I (−1 to −2 SD)
• Class II (↓ −2 SD)
A range of criteria based on
LBM (relative to stature)c
Sarcopenia LBM loss criterion, and
strength loss or
functional status
criteria metf
Myopenia
All-cause designation,
independent of age
LBM loss, affecting
functional status or
mortality
Sarcopenia class: SMI
• Class I (−1 to −2 SD)
• Class II (↓ −2 SD)
A range of criteria based on
ratio of LBM to body mass
(relative to body mass)d
Severe
Sarcopenia
All criteria are met
Skeletal Muscle
Function Deficit
All-cause designation,
independent of age
Diminished muscle
performancea,
affecting functional
status
Sarcopenic obesity LBM maintenance or loss, and
body fat criterion mete
aMuscle performance as measured by a given measure or estimate of strength, power, or capacity (e.g., endurance/fatigue; Correa-de-Araujo and Hadley, 2014).
bAppendicular lean mass (aLM/h2; men and women, respectively): 7.26 and 5.45 kg/m2 (Baumgartner et al., 1998); 6.12 and 5.29 kg/m2 (African American cohort;
Kelly et al., 2009); aLM scaled to body mass index (BMI): 0.789 and 0.512 (aLMBMI ; men and women, respectively; Dam et al., 2014); use of a single criterion
for sarcopenia involving lean body mass (LBM) may include adjustments for height, body fat, and/or body mass by some investigators (Cruz-Jentoft and Morley,
2012).
cClass I: 8.51–10.75 kg/m2 in men, and 5.76–6.75 kg/m2 in women; Class II: ≤8.50 kg/m2 in men, and ≤5.75 kg/m2 in women (Janssen et al., 2004a,b).
d Class I: 31–37% in men, and 22–28% in women; Class II: ≤30% in men, and ≤21% in women [SMI, skeletal muscle mass index; (muscle mass/body mass) *
100; Janssen et al., 2002].
eBody fat percentage (BF%): 27% in men and 38% in women (Baumgartner, 2000); BMI: ≥30 kg/m2 (Schrager et al., 2007); cohort specific criteria: 2 highest
quintiles of BF% and 2 lowest quintiles of lean body mass (Gomez-Cabello et al., 2011).
f Grip strength: <30 kg in men, and <20 kg in women (Murphy et al., 2013); <26 kg in men, and <16 kg in women (Dam et al., 2014); gait speed: <0.8 m/s (Cruz-Jentoft
et al., 2010); gait speed or distance: <1.0 m/s or <400 m during the 6-min walk test (Morley et al., 2011).
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and thighs, whereas African Americans
have greater subscapular skinfold thick-
ness (Zillikens and Conway, 1990; Nindl
et al., 1998). These phenotypic patterns
may confound body composition assess-
ment methods that do not account for
these factors. Consequently, an alternative
LBM density value of 1.13 g/cm3 has been
proposed for African Americans instead of
the 1.10 g/cm3 value typically used in body
composition models (Schutte et al., 1984).
The most common whole body tissue
composition methods used in sarcope-
nia research include anthropometry,
bioelectrical impedance (BIA), and
DXA. Anthropometry is often used in
community-health settings and consti-
tutes a broad assessment category that
features extremity circumferential mea-
surements, body mass index (BMI), and
skin fold measurements. While circum-
ferential measurements have been shown
to be associated with diminished activi-
ties of daily living (ADL) (Baumgartner
et al., 1998), their use as proxy body
composition measures systematically
underestimate LBM in African Americans
based on comparative differences in LBM
density, body fat distribution, and even
relative body proportions (Wagner and
Heyward, 2000). BMI has served as a
valuable predictor of critical health out-
comes (Kane et al., 2011), but also does
not account for racial/ethnic differences
in LBM density or body fat distribution
and may overestimate the obesity rates
in African Americans (Kleerekoper et al.,
1994). Skin fold measurements have lim-
itations similar to the aforementioned
anthropometric methods, and have also
been shown to underestimate LBM den-
sity in African Americans (Schutte et al.,
1984). In addition, BIA has been used
extensively to characterize body composi-
tion in population-based studies (Janssen
et al., 2002, 2004b; Chien et al., 2008).
The interpretation of body composition
data involving African Americans and
BIA measures may be limited due to
assumptions concerning body fat distri-
bution and relative body proportions.
However, Wagner et al. (1997) have
identified a validated predictive model
appropriate for use in this population.
Their use of the Segal adiposity-specific
equations, with expanded categories per
the Stolarczyk modification, yields fairly
accurate body composition measures for
African Americans, underestimating FFM
by 1.8 kg. While lacking the portability
of anthropometry and BIA, DXA esti-
mates of muscle mass have a high degree
of association with TBK and the imaging
method serves as a direct measure of BMD
(Wagner and Heyward, 2000; Cruz-Jentoft
and Morley, 2012). Therefore, DXA may
not be unduly influenced by racial/ethnic
differences in LBM density and may serve
as an ideal method to assess sarcopenia
in studies with multiracial participants
and for clinical practice in hospital set-
tings (sarcopenic LBM criterion values,
Table 1).
THE PREVALENCE AND
CONSEQUENCES OF SARCOPENIA IN
AFRICAN AMERICANS
Despite the substantial clinical and finan-
cial burden attributed to sarcopenia, this
geriatric syndrome remains an under-
diagnosed condition and is rarely sub-
ject to a systematic screening process as a
part of customary medical care for older
adults (Fielding et al., 2011). The sar-
copenia syndrome diminishes functional
independence and results in a 3–4 times
increased likelihood of developing a dis-
ability. In addition, sarcopenia may exac-
erbate hip fracture incidence due to the
loss of requisite strength to maintain
dynamic balance (Kamel, 2003). However,
while some investigators have shown a
significant relationship among diminished
LBM, impaired lower extremity strength,
functional performance, and disability
(Malmstrom et al., 2013), others have
reported that a negligible association exists
between LBM and disability in commu-
nity dwelling older adults (Visser et al.,
2000). Walking speed, fall risk, negotiat-
ing stairs, basic mobility, and independent
living status may be more dependent on
lower extremity strength and power rather
than LBM in older adults (Visser et al.,
2000; Kamel, 2003).
The discordance between the age-
related loss of muscle mass and diminished
function has been observed across ethnic
groups. However, this non-intuitive clini-
cal observation is most evident in African
Americans. Few studies have reported
epidemiological data by ethnic or racial
group for sarcopenia. Investigators using
data from the Health Aging and Body
Composition Study found that 14.3 and
18.4% of African American men and
women, respectively, were classified as sar-
copenic when adjusting for height and
body fat (Newman et al., 2003). Others
have noted a prevalence in Caucasians
above 25% for men and women across all
ages, whereas these values were reported
as low as 6–12% in African Americans
(Kan, 2009). Nevertheless, studies involv-
ing older, community-dwelling, African
Americans consistently demonstrate that
they have diminished functional perfor-
mance, and higher levels of dependence
with ADLs and risk of disabling condi-
tions, in comparison to other racial/ethnic
groups (Miller et al., 2005). What accounts
for older African Americans having a
higher prevalence of functional limitations
and ADL difficulty despite their lower
prevalence of sarcopenia?
Both Janssen and Visser have recog-
nized high body fat levels as a confounder
in the investigations into the associa-
tion of LBM with functional limitations
and disability (Janssen et al., 2002; Visser
et al., 2002). The consideration of body
fat and body mass adds an important
dimension to the sarcopenia syndrome
given that unchanging muscle mass cou-
pled with increased body fat may por-
tend significant functional and metabolic
decline (Cruz-Jentoft and Morley, 2012).
Moreover, myosteatosis (an increased pro-
portion of intramuscular adipose tis-
sue) has been observed in older adults
of African ancestry, and this deleterious
adaptation to aging may occur to a greater
degree in comparison to Caucasians even
when subcutaneous and visceral fat lev-
els are similar among the groups (Song
et al., 2004; Miljkovic-Gacic et al., 2008).
While the higher risk of disabling condi-
tions observed in African Americans likely
involves an array of socioeconomic factors
(Fuller-Thomson et al., 2009), high lev-
els of myosteatosis are strongly associated
with impaired lower extremity function
and may serve as a possible explanation
for the departure in linearity between
muscle wasting and physical performance
(Goodpaster et al., 2001).
Non-contractile features of muscle also
affect health outcomes as age-related
changes in skeletal muscle may be a critical
progenitor of metabolic abnormalities
(Albu et al., 2005). While preliminary
www.frontiersin.org July 2014 | Volume 5 | Article 250 | 3
Harris-Love et al. Sarcopenia in African American Veterans
findings suggest that relative muscle mass
may be more strongly associated with
insulin resistance than strength (Bijlsma
et al., 2013), there are divergent views on
this point (Kamel, 2003; Sayer et al., 2005).
Data from the NHANES III cohort reveal
that sarcopenia is strongly associated with
the homeostasis model assessment of
insulin resistance and higher HbA1C lev-
els in both non-obese and obese individ-
uals under 60 years of age (Srikanthan
et al., 2010). However, the relationship
between sarcopenia and a higher preva-
lence of type 2 diabetes was only observed
in obese individuals. Miljkovic et al. (2009)
determined that Afro-Caribbean men had
higher myosteatosis levels and a lower
body fat percentage in comparison to
Caucasian men. Myosteatosis was associ-
ated with type 2 diabetes in both groups,
but 44% of the Afro-Caribbean men were
diagnosed with the metabolic disorder in
comparison to 13% of the Caucasian men.
While the negative impact of low muscle
mass on glucose homeostasis cannot be
discounted (Bijlsma et al., 2013), excessive
intramuscular adipose tissue and intramy-
ocellular lipid content may disrupt insulin
receptor activity, limit glucose transport,
and potentially result in adipokine release
from local concentrations of adipose tissue
(Miljkovic et al., 2009). The case could be
made to incorporate age-related changes
in muscle quality into the broad view of
the sarcopenia diagnosis. However, more
prospective study will be needed to better
understand the role of myosteatosis in the
pathogenesis of diminished insulin sen-
sitivity and diabetes. Given that African
Americans are 1.6–1.7 times as likely to
have diabetes in comparison to Caucasians
within the VA and civilian population,
it may be a compelling interest of the
Federal health agencies, professional and
scientific organizations, and other stake-
holders to study the impact of age-related
muscle changes and how they interact
with racial/ethnic group factors in health
disparities (National Center for Veterans
Analysis and Statistics, 2011).
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